endothelial nitric oxide synthase (eNOS) gene therapy (Taxus)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameendothelial nitric oxide synthase (eNOS) gene therapy (Taxus)
Drug Alias NamePAOD gene therapy (Cardium)PVD gene therapy (Cardium)endothelial nitric oxide synthase (eNOS) gene therapy (Cardium)Genvascor
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionAngiogenesis stimulantsNitric-oxide synthase, endothelial modulators
TargetsNitric-oxide synthase, endothelial
Therapy Area/IndicationsPeripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWestern Europe
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCollateral Therapeutics, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCollateral Therapeutics, IncGene Biotherapeutics IncBayer Schering Pharma AG
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A